These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9308007)

  • 1. Expression of a D2 dopamine receptor antisense RNA in brain inhibits D2-mediated behaviors.
    Weiss B; Davidkova G; Zhou LW; Zhang SP; Morabito M
    Neurochem Int; 1997 Oct; 31(4):571-80. PubMed ID: 9308007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrastriatal administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor mRNA inhibits D2 dopamine receptor-mediated behavior and D2 dopamine receptors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhou LW; Zhang SP; Weiss B
    Neurochem Int; 1996 Dec; 29(6):583-95. PubMed ID: 9113126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum.
    Zhou LW; Zhang SP; Qin ZH; Weiss B
    J Pharmacol Exp Ther; 1994 Feb; 268(2):1015-23. PubMed ID: 8113958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors.
    Qin ZH; Chen JF; Weiss B
    J Neurochem; 1994 Feb; 62(2):411-20. PubMed ID: 8294904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic lesions of mouse striatum induced by AF64A alter D2 dopaminergic behavior and reduce D2 dopamine receptors and D2 dopamine receptor mRNA.
    Zhou LW; Zhang SP; Connell TA; Weiss B
    Neurochem Int; 1993 Mar; 22(3):301-11. PubMed ID: 8443571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA.
    Weiss B; Zhou LW; Zhang SP; Qin ZH
    Neuroscience; 1993 Aug; 55(3):607-12. PubMed ID: 8413923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP; Zhou LW; Weiss B
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense strategies in dopamine receptor pharmacology.
    Weiss B; Zhang SP; Zhou LW
    Life Sci; 1997; 60(7):433-55. PubMed ID: 9042372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B
    Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal dopamine-rich implants reverse the changes in dopamine D2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: an autoradiographic study.
    Savasta M; Mennicken F; Chritin M; Abrous DN; Feuerstein C; Le Moal M; Herman JP
    Neuroscience; 1992; 46(3):729-38. PubMed ID: 1532053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis.
    Herman JP; Rouge-Pont F; Le Moal M; Abrous DN
    Neuroscience; 1993 Apr; 53(4):1083-95. PubMed ID: 8099430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ras homolog Rhes affects dopamine D1 and D2 receptor-mediated behavior in mice.
    Quintero GC; Spano D; Lahoste GJ; Harrison LM
    Neuroreport; 2008 Oct; 19(16):1563-6. PubMed ID: 18845937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
    Rajakumar N; Laurier L; Niznik HB; Stoessl AJ
    Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
    Silvia CP; King GR; Lee TH; Xue ZY; Caron MG; Ellinwood EH
    Mol Pharmacol; 1994 Jul; 46(1):51-7. PubMed ID: 8058056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats.
    Robertson GS; Fine A; Robertson HA
    Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific proportion of the two isoforms of the dopamine D2 receptor in the mouse striatum: associated neural and behavioral phenotypes.
    Colelli V; Fiorenza MT; Conversi D; Orsini C; Cabib S
    Genes Brain Behav; 2010 Oct; 9(7):703-11. PubMed ID: 20546314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
    Fletcher GH; Starr MS
    Neuroscience; 1987 Feb; 20(2):589-97. PubMed ID: 2953990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in D1/D2 synergism may account for enhanced stereotypy and reduced climbing in mice lacking dopamine D2L receptor.
    Fetsko LA; Xu R; Wang Y
    Brain Res; 2003 Mar; 967(1-2):191-200. PubMed ID: 12650980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.